TERNS PHARMACEUTICALS INC (TERN)
US8808811074 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -90.21M | -60.35M | -50.16M | -40.57M | -68.82M | |||
| Depreciation Amortization | 292.00K | 480.00K | 510.00K | 390.00K | 200.00K | |||
| Income Taxes - Deferred | 141.00K | 390.00K | 220.00K | 690.00K | N/A | |||
| Change In Working Capital | 1.29M | -1.04M | -1.43M | 5.06M | 1.77M | |||
| Taxes Paid | 28.00K | 0.00 | 240.00K | 180.00K | 70.00K | |||
| Other non cash items | 21.10M | 11.40M | 9.03M | 4.62M | 630.00K | |||
| OPERATING CASH FLOW | -67.39M | -49.11M | -41.83M | -29.81M | -66.22M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -52.00K | -280.00K | -340.00K | -580.00K | -900.00K | |||
| Other Investing Activity | -37.94M | -22.00M | -119.36M | 7.28M | -2.96M | |||
| INVESTING CASH FLOW | -37.99M | -22.27M | -119.70M | 6.69M | -3.86M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -160.00K | 16.88M | N/A | |||
| Stock Issued/Repurchased | 42.30M | 167.50M | 137.28M | 69.50M | 30.00K | |||
| Other Financing Activity | -344.00K | -400.00K | -2.72M | -860.00K | 40.00K | |||
| FINANCING CASH FLOW | 41.95M | 167.10M | 134.39M | 85.52M | 60.00K | |||
| Exchange Rate Effect | 117.00K | -180.00K | -30.00K | 80.00K | -130.00K | |||
| CHANGE IN CASH | -63.31M | 95.54M | -27.17M | 62.48M | -70.15M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -67.39M | -49.11M | -41.83M | -29.81M | -66.22M | |||
| Capital Expenditure | -52.00K | -280.00K | -340.00K | -580.00K | -900.00K | |||
| FREE CASH FLOW | -67.44M | -49.39M | -42.17M | -30.39M | -67.12M | |||
All data in USD